— Know what they know.
Not Investment Advice

TECH NASDAQ

Bio-Techne Corporation
1W: +6.0% 1M: -19.1% 3M: -17.7% YTD: -20.5% 1Y: -4.1% 3Y: -41.5% 5Y: -51.9%
$48.21
+0.84 (+1.77%)
 
Weekly Expected Move ±12.2%
$33 $38 $43 $49 $54
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 38 · $7.5B mcap · 155M float · 1.68% daily turnover · Short 51% of daily vol

Cash Flow Trends

Operating Cash Flow
$288M -3.8% ▼
5Y CAGR: +7.0%
Capital Expenditures
$31M +50.7% ▲
5Y CAGR: -9.7%
Free Cash Flow
$257M +8.7% ▲
5Y CAGR: +10.8%
Dividends Paid
$50M +0.1% ▲
Buybacks
$276M -244.5% ▼
Net Change in Cash
$10M +136.1% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$140M$263M$285M$168M$73M
Depreciation & Amort.$88M$101M$107M$112M$110M
Stock-Based Comp.$49M$42M$39M$38M$41M
Change in Working Capital$29M-$70M-$91M-$10M$12M
Other Non-Cash Items$74M-$18M-$57M$31M$103M
Operating Cash Flow$352M$325M$254M$299M$288M
— Investing Activities —
Capital Expenditures-$44M-$45M-$38M-$63M-$31M
Acquisitions (Net)-$226M$0-$83M-$170M-$15M
Investment Purchases-$40M-$25M-$20M-$6M-$6M
Investment Sales$66M$26M$108M$28M$1M
Other Investing$0-$53M-$232M$7M$15M
Investing Cash Flow-$244M-$97M-$266M-$203M-$35M
— Financing Activities —
Net Debt Issuance-$16M-$86M$94M-$31M$27M
Stock Repurchased-$43M-$161M-$20M-$80M-$276M
Dividends Paid-$50M-$50M-$50M-$50M-$50M
Other Financing$46M$54M-$2M$39M$45M
Financing Cash Flow-$63M-$243M$23M-$122M-$254M
Net Change in Cash$52M-$27M$8M-$29M$10M
Cash End of Period$199M$173M$181M$152M$162M
Free Cash Flow$308M$280M$216M$236M$257M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms